Cargando…

Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions

BACKGROUND: It is difficult to identify pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions through conventional CT or MR examination. As an innovative image analysis method, radiomics may possess potential clinical value in identifying PDAC and MFCP. To deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yan, Ming, Bing, Zhou, Ting, Wu, Jia-long, Chen, Yong, Liu, Pei, Zhang, Ju, Zhang, Shi-yong, Chen, Tian-wu, Zhang, Xiao-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025779/
https://www.ncbi.nlm.nih.gov/pubmed/33842325
http://dx.doi.org/10.3389/fonc.2021.620981
_version_ 1783675555246243840
author Deng, Yan
Ming, Bing
Zhou, Ting
Wu, Jia-long
Chen, Yong
Liu, Pei
Zhang, Ju
Zhang, Shi-yong
Chen, Tian-wu
Zhang, Xiao-Ming
author_facet Deng, Yan
Ming, Bing
Zhou, Ting
Wu, Jia-long
Chen, Yong
Liu, Pei
Zhang, Ju
Zhang, Shi-yong
Chen, Tian-wu
Zhang, Xiao-Ming
author_sort Deng, Yan
collection PubMed
description BACKGROUND: It is difficult to identify pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions through conventional CT or MR examination. As an innovative image analysis method, radiomics may possess potential clinical value in identifying PDAC and MFCP. To develop and validate radiomics models derived from multiparametric MRI to distinguish pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions. METHODS: This retrospective study included 119 patients from two independent institutions. Patients from one institution were used as the training cohort (51 patients with PDAC and 13 patients with MFCP), and patients from the other institution were used as the testing cohort (45 patients with PDAC and 10 patients with MFCP). All the patients had pathologically confirmed results, and preoperative MRI was performed. Four feature sets were extracted from T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and the artery (A) and portal (P) phases of dynamic contrast-enhanced MRI, and the corresponding radiomics models were established. Several clinical characteristics were used to discriminate PDAC and MFCP lesions, and clinical model was established. The results of radiologists’ evaluation were compared with pathology and radiomics models. Univariate analysis and the least absolute shrinkage and selection operator algorithm were performed for feature selection, and a support vector machine was used for classification. The receiver operating characteristic (ROC) curve was applied to assess the model discrimination. RESULTS: The areas under the ROC curves (AUCs) for the T1WI, T2WI, A and, P and clinical models were 0.893, 0.911, 0.958, 0.997 and 0.516 in the primary cohort, and 0.882, 0.902, 0.920, 0.962 and 0.649 in the validation cohort, respectively. All radiomics models performed better than clinical model and radiologists’ evaluation both in the training and testing cohorts by comparing the AUC of various models, all P<0.050. Good calibration was achieved. CONCLUSIONS: The radiomics models based on multiparametric MRI have the potential ability to classify PDAC and MFCP lesions.
format Online
Article
Text
id pubmed-8025779
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80257792021-04-08 Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions Deng, Yan Ming, Bing Zhou, Ting Wu, Jia-long Chen, Yong Liu, Pei Zhang, Ju Zhang, Shi-yong Chen, Tian-wu Zhang, Xiao-Ming Front Oncol Oncology BACKGROUND: It is difficult to identify pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions through conventional CT or MR examination. As an innovative image analysis method, radiomics may possess potential clinical value in identifying PDAC and MFCP. To develop and validate radiomics models derived from multiparametric MRI to distinguish pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions. METHODS: This retrospective study included 119 patients from two independent institutions. Patients from one institution were used as the training cohort (51 patients with PDAC and 13 patients with MFCP), and patients from the other institution were used as the testing cohort (45 patients with PDAC and 10 patients with MFCP). All the patients had pathologically confirmed results, and preoperative MRI was performed. Four feature sets were extracted from T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and the artery (A) and portal (P) phases of dynamic contrast-enhanced MRI, and the corresponding radiomics models were established. Several clinical characteristics were used to discriminate PDAC and MFCP lesions, and clinical model was established. The results of radiologists’ evaluation were compared with pathology and radiomics models. Univariate analysis and the least absolute shrinkage and selection operator algorithm were performed for feature selection, and a support vector machine was used for classification. The receiver operating characteristic (ROC) curve was applied to assess the model discrimination. RESULTS: The areas under the ROC curves (AUCs) for the T1WI, T2WI, A and, P and clinical models were 0.893, 0.911, 0.958, 0.997 and 0.516 in the primary cohort, and 0.882, 0.902, 0.920, 0.962 and 0.649 in the validation cohort, respectively. All radiomics models performed better than clinical model and radiologists’ evaluation both in the training and testing cohorts by comparing the AUC of various models, all P<0.050. Good calibration was achieved. CONCLUSIONS: The radiomics models based on multiparametric MRI have the potential ability to classify PDAC and MFCP lesions. Frontiers Media S.A. 2021-03-24 /pmc/articles/PMC8025779/ /pubmed/33842325 http://dx.doi.org/10.3389/fonc.2021.620981 Text en Copyright © 2021 Deng, Ming, Zhou, Wu, Chen, Liu, Zhang, Zhang, Chen and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Deng, Yan
Ming, Bing
Zhou, Ting
Wu, Jia-long
Chen, Yong
Liu, Pei
Zhang, Ju
Zhang, Shi-yong
Chen, Tian-wu
Zhang, Xiao-Ming
Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
title Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
title_full Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
title_fullStr Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
title_full_unstemmed Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
title_short Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
title_sort radiomics model based on mr images to discriminate pancreatic ductal adenocarcinoma and mass-forming chronic pancreatitis lesions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025779/
https://www.ncbi.nlm.nih.gov/pubmed/33842325
http://dx.doi.org/10.3389/fonc.2021.620981
work_keys_str_mv AT dengyan radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT mingbing radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT zhouting radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT wujialong radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT chenyong radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT liupei radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT zhangju radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT zhangshiyong radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT chentianwu radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions
AT zhangxiaoming radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions